This is the first of five chapters that comprise Part IV of the book. These chapters demonstrate RMM as a platform for empirical modeling of random variation. The claim of RMM for a "universal" ...

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) is preparing to trial new timelines for variation applications to “provide greater clarity and more effective monitoring.” NPRA published ...